🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

307,02 USD

Máx. histórico

322,75

3 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-4,87%

Rango 52 semanas

175,89 – 326,63

Variación hoy

-4,87%

Cierre anterior

322,75

Rango de hoy

306,17 – 324,95

Volumen hoy

265.433

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
32,35 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 21 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/05/1993 32,75 35,56 32,75 33,69 +1,41% 8,57% 2.111
05/05/1993 35,56 35,56 32,75 33,22 -4,05% 7,89% 7.240
04/05/1993 32,75 35,56 32,75 34,62 +0,00% 8,57% 1.069
03/05/1993 35,56 35,56 32,75 34,62 -5,13% 7,89% 321
30/04/1993 35,56 36,49 35,56 36,49 +2,63% 2,63% 294
29/04/1993 35,56 35,56 35,56 35,56 +2,70% 0,00% 134
28/04/1993 33,69 36,49 33,69 34,62 +0,00% 8,33% 802
27/04/1993 34,62 36,49 34,62 34,62 +0,00% 5,41% 2.939
26/04/1993 37,43 37,43 34,62 34,62 -7,50% 7,50% 668
23/04/1993 37,43 37,43 34,62 37,43 +3,90% 7,50% 427
22/04/1993 35,56 36,03 34,62 36,03 +4,05% 3,95% 908
21/04/1993 34,62 35,56 34,62 34,62 +0,00% 2,70% 2.458
20/04/1993 34,62 34,62 34,62 34,62 +0,00% 0,00% 508
19/04/1993 34,62 37,43 34,62 34,62 -3,90% 8,11% 1.202
16/04/1993 34,62 37,43 34,62 36,03 +0,00% 8,11% 1.710
15/04/1993 37,43 37,43 36,03 36,03 +4,05% 3,75% 160
14/04/1993 37,43 37,43 34,62 34,62 -1,33% 7,50% 83.196
13/04/1993 37,43 37,43 34,62 35,09 -6,25% 7,50% 882
12/04/1993 34,62 37,43 34,62 37,43 +8,11% 8,11% 1.656
08/04/1993 36,49 39,30 34,62 34,62 -7,50% 12,82% 2.538
07/04/1993 36,49 39,30 36,49 37,43 +2,56% 7,69% 2.939
06/04/1993 39,30 39,30 36,49 36,49 -2,50% 7,14% 534
05/04/1993 37,43 38,37 36,49 37,43 +0,00% 5,00% 1.950
02/04/1993 37,43 38,37 37,43 37,43 -1,23% 2,50% 748
01/04/1993 37,43 38,37 34,62 37,90 +3,85% 10,00% 3.206
31/03/1993 37,43 37,43 34,62 36,49 +5,41% 7,50% 1.256
30/03/1993 34,62 36,96 34,62 34,62 -7,50% 6,76% 2.992
29/03/1993 37,43 37,43 34,62 37,43 +0,00% 7,50% 267
26/03/1993 34,62 37,43 34,62 37,43 +2,56% 8,11% 4.034
25/03/1993 35,56 36,49 33,69 36,49 +5,41% 7,89% 1.924